Table of Content

1 Study Coverage
1.1 CAR-T Cell Therapy Product Introduction
1.2 Market by Type
1.2.1 Global CAR-T Cell Therapy Market Size Growth Rate by Type, 2018 VS 2022 VS 2033
1.2.2 CD19
1.2.3 BCMA
1.2.4 CD19/CD22
1.2.5 Other
1.3 Market by Application
1.3.1 Global CAR-T Cell Therapy Market Size Growth Rate by Application, 2018 VS 2022 VS 2033
1.3.2 Non-hodgkin Lymphoma
1.3.3 Multiple Myeloma
1.3.4 Acute Lymphoblastic Leukemia
1.3.5 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global CAR-T Cell Therapy Sales Estimates and Forecasts 2018-2033
2.2 Global CAR-T Cell Therapy Revenue by Region
2.2.1 Global CAR-T Cell Therapy Revenue by Region: 2018 VS 2022 VS 2033
2.2.2 Global CAR-T Cell Therapy Revenue by Region (2018-2023)
2.2.3 Global CAR-T Cell Therapy Revenue by Region (2024-2033)
2.2.4 Global CAR-T Cell Therapy Revenue Market Share by Region (2018-2033)
2.3 Global CAR-T Cell Therapy Sales Estimates and Forecasts 2018-2033
2.4 Global CAR-T Cell Therapy Sales by Region
2.4.1 Global CAR-T Cell Therapy Sales by Region: 2018 VS 2022 VS 2033
2.4.2 Global CAR-T Cell Therapy Sales by Region (2018-2023)
2.4.3 Global CAR-T Cell Therapy Sales by Region (2024-2033)
2.4.4 Global CAR-T Cell Therapy Sales Market Share by Region (2018-2033)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global CAR-T Cell Therapy Sales by Manufacturers
3.1.1 Global CAR-T Cell Therapy Sales by Manufacturers (2018-2023)
3.1.2 Global CAR-T Cell Therapy Sales Market Share by Manufacturers (2018-2023)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of CAR-T Cell Therapy in 2022
3.2 Global CAR-T Cell Therapy Revenue by Manufacturers
3.2.1 Global CAR-T Cell Therapy Revenue by Manufacturers (2018-2023)
3.2.2 Global CAR-T Cell Therapy Revenue Market Share by Manufacturers (2018-2023)
3.2.3 Global Top 10 and Top 5 Companies by CAR-T Cell Therapy Revenue in 2022
3.3 Global Key Players of CAR-T Cell Therapy, Industry Ranking, 2021 VS 2022 VS 2023
3.4 Global CAR-T Cell Therapy Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global CAR-T Cell Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of CAR-T Cell Therapy, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of CAR-T Cell Therapy, Product Offered and Application
3.8 Global Key Manufacturers of CAR-T Cell Therapy, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global CAR-T Cell Therapy Sales by Type
4.1.1 Global CAR-T Cell Therapy Historical Sales by Type (2018-2023)
4.1.2 Global CAR-T Cell Therapy Forecasted Sales by Type (2024-2033)
4.1.3 Global CAR-T Cell Therapy Sales Market Share by Type (2018-2033)
4.2 Global CAR-T Cell Therapy Revenue by Type
4.2.1 Global CAR-T Cell Therapy Historical Revenue by Type (2018-2023)
4.2.2 Global CAR-T Cell Therapy Forecasted Revenue by Type (2024-2033)
4.2.3 Global CAR-T Cell Therapy Revenue Market Share by Type (2018-2033)
4.3 Global CAR-T Cell Therapy Price by Type
4.3.1 Global CAR-T Cell Therapy Price by Type (2018-2023)
4.3.2 Global CAR-T Cell Therapy Price Forecast by Type (2024-2033)
5 Market Size by Application
5.1 Global CAR-T Cell Therapy Sales by Application
5.1.1 Global CAR-T Cell Therapy Historical Sales by Application (2018-2023)
5.1.2 Global CAR-T Cell Therapy Forecasted Sales by Application (2024-2033)
5.1.3 Global CAR-T Cell Therapy Sales Market Share by Application (2018-2033)
5.2 Global CAR-T Cell Therapy Revenue by Application
5.2.1 Global CAR-T Cell Therapy Historical Revenue by Application (2018-2023)
5.2.2 Global CAR-T Cell Therapy Forecasted Revenue by Application (2024-2033)
5.2.3 Global CAR-T Cell Therapy Revenue Market Share by Application (2018-2033)
5.3 Global CAR-T Cell Therapy Price by Application
5.3.1 Global CAR-T Cell Therapy Price by Application (2018-2023)
5.3.2 Global CAR-T Cell Therapy Price Forecast by Application (2024-2033)
6 US & Canada
6.1 US & Canada CAR-T Cell Therapy Market Size by Type
6.1.1 US & Canada CAR-T Cell Therapy Sales by Type (2018-2033)
6.1.2 US & Canada CAR-T Cell Therapy Revenue by Type (2018-2033)
6.2 US & Canada CAR-T Cell Therapy Market Size by Application
6.2.1 US & Canada CAR-T Cell Therapy Sales by Application (2018-2033)
6.2.2 US & Canada CAR-T Cell Therapy Revenue by Application (2018-2033)
6.3 US & Canada CAR-T Cell Therapy Market Size by Country
6.3.1 US & Canada CAR-T Cell Therapy Revenue by Country: 2018 VS 2022 VS 2033
6.3.2 US & Canada CAR-T Cell Therapy Sales by Country (2018-2033)
6.3.3 US & Canada CAR-T Cell Therapy Revenue by Country (2018-2033)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe CAR-T Cell Therapy Market Size by Type
7.1.1 Europe CAR-T Cell Therapy Sales by Type (2018-2033)
7.1.2 Europe CAR-T Cell Therapy Revenue by Type (2018-2033)
7.2 Europe CAR-T Cell Therapy Market Size by Application
7.2.1 Europe CAR-T Cell Therapy Sales by Application (2018-2033)
7.2.2 Europe CAR-T Cell Therapy Revenue by Application (2018-2033)
7.3 Europe CAR-T Cell Therapy Market Size by Country
7.3.1 Europe CAR-T Cell Therapy Revenue by Country: 2018 VS 2022 VS 2033
7.3.2 Europe CAR-T Cell Therapy Sales by Country (2018-2033)
7.3.3 Europe CAR-T Cell Therapy Revenue by Country (2018-2033)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China CAR-T Cell Therapy Market Size
8.1.1 China CAR-T Cell Therapy Sales (2018-2033)
8.1.2 China CAR-T Cell Therapy Revenue (2018-2033)
8.2 China CAR-T Cell Therapy Market Size by Application
8.2.1 China CAR-T Cell Therapy Sales by Application (2018-2033)
8.2.2 China CAR-T Cell Therapy Revenue by Application (2018-2033)
9 Asia (excluding China)
9.1 Asia CAR-T Cell Therapy Market Size by Type
9.1.1 Asia CAR-T Cell Therapy Sales by Type (2018-2033)
9.1.2 Asia CAR-T Cell Therapy Revenue by Type (2018-2033)
9.2 Asia CAR-T Cell Therapy Market Size by Application
9.2.1 Asia CAR-T Cell Therapy Sales by Application (2018-2033)
9.2.2 Asia CAR-T Cell Therapy Revenue by Application (2018-2033)
9.3 Asia CAR-T Cell Therapy Sales by Region
9.3.1 Asia CAR-T Cell Therapy Revenue by Region: 2018 VS 2022 VS 2033
9.3.2 Asia CAR-T Cell Therapy Revenue by Region (2018-2033)
9.3.3 Asia CAR-T Cell Therapy Sales by Region (2018-2033)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America CAR-T Cell Therapy Market Size by Type
10.1.1 Middle East, Africa and Latin America CAR-T Cell Therapy Sales by Type (2018-2033)
10.1.2 Middle East, Africa and Latin America CAR-T Cell Therapy Revenue by Type (2018-2033)
10.2 Middle East, Africa and Latin America CAR-T Cell Therapy Market Size by Application
10.2.1 Middle East, Africa and Latin America CAR-T Cell Therapy Sales by Application (2018-2033)
10.2.2 Middle East, Africa and Latin America CAR-T Cell Therapy Revenue by Application (2018-2033)
10.3 Middle East, Africa and Latin America CAR-T Cell Therapy Sales by Country
10.3.1 Middle East, Africa and Latin America CAR-T Cell Therapy Revenue by Country: 2018 VS 2022 VS 2033
10.3.2 Middle East, Africa and Latin America CAR-T Cell Therapy Revenue by Country (2018-2033)
10.3.3 Middle East, Africa and Latin America CAR-T Cell Therapy Sales by Country (2018-2033)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 Bristol Myers Squibb
11.1.1 Bristol Myers Squibb Company Information
11.1.2 Bristol Myers Squibb Overview
11.1.3 Bristol Myers Squibb CAR-T Cell Therapy Sales, Price, Revenue and Gross Margin (2018-2023)
11.1.4 Bristol Myers Squibb CAR-T Cell Therapy Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Bristol Myers Squibb Recent Developments
11.2 Gilead Sciences
11.2.1 Gilead Sciences Company Information
11.2.2 Gilead Sciences Overview
11.2.3 Gilead Sciences CAR-T Cell Therapy Sales, Price, Revenue and Gross Margin (2018-2023)
11.2.4 Gilead Sciences CAR-T Cell Therapy Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Gilead Sciences Recent Developments
11.3 Novartis
11.3.1 Novartis Company Information
11.3.2 Novartis Overview
11.3.3 Novartis CAR-T Cell Therapy Sales, Price, Revenue and Gross Margin (2018-2023)
11.3.4 Novartis CAR-T Cell Therapy Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Novartis Recent Developments
11.4 Autolus
11.4.1 Autolus Company Information
11.4.2 Autolus Overview
11.4.3 Autolus CAR-T Cell Therapy Sales, Price, Revenue and Gross Margin (2018-2023)
11.4.4 Autolus CAR-T Cell Therapy Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Autolus Recent Developments
11.5 Janssen
11.5.1 Janssen Company Information
11.5.2 Janssen Overview
11.5.3 Janssen CAR-T Cell Therapy Sales, Price, Revenue and Gross Margin (2018-2023)
11.5.4 Janssen CAR-T Cell Therapy Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Janssen Recent Developments
11.6 JW Therapeutics
11.6.1 JW Therapeutics Company Information
11.6.2 JW Therapeutics Overview
11.6.3 JW Therapeutics CAR-T Cell Therapy Sales, Price, Revenue and Gross Margin (2018-2023)
11.6.4 JW Therapeutics CAR-T Cell Therapy Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 JW Therapeutics Recent Developments
11.7 Beijing Immunochina Medical Science & Technology
11.7.1 Beijing Immunochina Medical Science & Technology Company Information
11.7.2 Beijing Immunochina Medical Science & Technology Overview
11.7.3 Beijing Immunochina Medical Science & Technology CAR-T Cell Therapy Sales, Price, Revenue and Gross Margin (2018-2023)
11.7.4 Beijing Immunochina Medical Science & Technology CAR-T Cell Therapy Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Beijing Immunochina Medical Science & Technology Recent Developments
11.8 Bioray Laboratories
11.8.1 Bioray Laboratories Company Information
11.8.2 Bioray Laboratories Overview
11.8.3 Bioray Laboratories CAR-T Cell Therapy Sales, Price, Revenue and Gross Margin (2018-2023)
11.8.4 Bioray Laboratories CAR-T Cell Therapy Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Bioray Laboratories Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 CAR-T Cell Therapy Industry Chain Analysis
12.2 CAR-T Cell Therapy Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 CAR-T Cell Therapy Production Mode & Process
12.4 CAR-T Cell Therapy Sales and Marketing
12.4.1 CAR-T Cell Therapy Sales Channels
12.4.2 CAR-T Cell Therapy Distributors
12.5 CAR-T Cell Therapy Customers
13 Market Dynamics
13.1 CAR-T Cell Therapy Industry Trends
13.2 CAR-T Cell Therapy Market Drivers
13.3 CAR-T Cell Therapy Market Challenges
13.4 CAR-T Cell Therapy Market Restraints
14 Key Findings in The Global CAR-T Cell Therapy Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Figure

List of Tables
Table 1. Global CAR-T Cell Therapy Market Size Growth Rate by Type, 2018 VS 2022 VS 2033 (US$ Million)
Table 2. Major Manufacturers of CD19
Table 3. Major Manufacturers of BCMA
Table 4. Major Manufacturers of CD19/CD22
Table 5. Major Manufacturers of Other
Table 6. Global CAR-T Cell Therapy Market Size Growth Rate by Application, 2018 VS 2022 VS 2033 (US$ Million)
Table 7. Global CAR-T Cell Therapy Revenue Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2033 (US$ Million)
Table 8. Global CAR-T Cell Therapy Revenue by Region (2018-2023) & (US$ Million)
Table 9. Global CAR-T Cell Therapy Revenue by Region (2024-2033) & (US$ Million)
Table 10. Global CAR-T Cell Therapy Revenue Market Share by Region (2018-2023)
Table 11. Global CAR-T Cell Therapy Revenue Market Share by Region (2024-2033)
Table 12. Global CAR-T Cell Therapy Sales Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2033 (US$ Million)
Table 13. Global CAR-T Cell Therapy Sales by Region (2018-2023) & (K Units)
Table 14. Global CAR-T Cell Therapy Sales by Region (2024-2033) & (K Units)
Table 15. Global CAR-T Cell Therapy Sales Market Share by Region (2018-2023)
Table 16. Global CAR-T Cell Therapy Sales Market Share by Region (2024-2033)
Table 17. Global CAR-T Cell Therapy Sales by Manufacturers (2018-2023) & (K Units)
Table 18. Global CAR-T Cell Therapy Sales Share by Manufacturers (2018-2023)
Table 19. Global CAR-T Cell Therapy Revenue by Manufacturers (2018-2023) & (US$ Million)
Table 20. Global CAR-T Cell Therapy Revenue Share by Manufacturers (2018-2023)
Table 21. Global Key Players of CAR-T Cell Therapy, Industry Ranking, 2021 VS 2022 VS 2023
Table 22. CAR-T Cell Therapy Price by Manufacturers 2018-2023 (US$/Unit)
Table 23. Global CAR-T Cell Therapy Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 24. Global CAR-T Cell Therapy by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in CAR-T Cell Therapy as of 2022)
Table 25. Global Key Manufacturers of CAR-T Cell Therapy, Manufacturing Base Distribution and Headquarters
Table 26. Global Key Manufacturers of CAR-T Cell Therapy, Product Offered and Application
Table 27. Global Key Manufacturers of CAR-T Cell Therapy, Date of Enter into This Industry
Table 28. Mergers & Acquisitions, Expansion Plans
Table 29. Global CAR-T Cell Therapy Sales by Type (2018-2023) & (K Units)
Table 30. Global CAR-T Cell Therapy Sales by Type (2024-2033) & (K Units)
Table 31. Global CAR-T Cell Therapy Sales Share by Type (2018-2023)
Table 32. Global CAR-T Cell Therapy Sales Share by Type (2024-2033)
Table 33. Global CAR-T Cell Therapy Revenue by Type (2018-2023) & (US$ Million)
Table 34. Global CAR-T Cell Therapy Revenue by Type (2024-2033) & (US$ Million)
Table 35. Global CAR-T Cell Therapy Revenue Share by Type (2018-2023)
Table 36. Global CAR-T Cell Therapy Revenue Share by Type (2024-2033)
Table 37. CAR-T Cell Therapy Price by Type (2018-2023) & (US$/Unit)
Table 38. Global CAR-T Cell Therapy Price Forecast by Type (2024-2033) & (US$/Unit)
Table 39. Global CAR-T Cell Therapy Sales by Application (2018-2023) & (K Units)
Table 40. Global CAR-T Cell Therapy Sales by Application (2024-2033) & (K Units)
Table 41. Global CAR-T Cell Therapy Sales Share by Application (2018-2023)
Table 42. Global CAR-T Cell Therapy Sales Share by Application (2024-2033)
Table 43. Global CAR-T Cell Therapy Revenue by Application (2018-2023) & (US$ Million)
Table 44. Global CAR-T Cell Therapy Revenue by Application (2024-2033) & (US$ Million)
Table 45. Global CAR-T Cell Therapy Revenue Share by Application (2018-2023)
Table 46. Global CAR-T Cell Therapy Revenue Share by Application (2024-2033)
Table 47. CAR-T Cell Therapy Price by Application (2018-2023) & (US$/Unit)
Table 48. Global CAR-T Cell Therapy Price Forecast by Application (2024-2033) & (US$/Unit)
Table 49. US & Canada CAR-T Cell Therapy Sales by Type (2018-2023) & (K Units)
Table 50. US & Canada CAR-T Cell Therapy Sales by Type (2024-2033) & (K Units)
Table 51. US & Canada CAR-T Cell Therapy Revenue by Type (2018-2023) & (US$ Million)
Table 52. US & Canada CAR-T Cell Therapy Revenue by Type (2024-2033) & (US$ Million)
Table 53. US & Canada CAR-T Cell Therapy Sales by Application (2018-2023) & (K Units)
Table 54. US & Canada CAR-T Cell Therapy Sales by Application (2024-2033) & (K Units)
Table 55. US & Canada CAR-T Cell Therapy Revenue by Application (2018-2023) & (US$ Million)
Table 56. US & Canada CAR-T Cell Therapy Revenue by Application (2024-2033) & (US$ Million)
Table 57. US & Canada CAR-T Cell Therapy Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2033 (US$ Million)
Table 58. US & Canada CAR-T Cell Therapy Revenue by Country (2018-2023) & (US$ Million)
Table 59. US & Canada CAR-T Cell Therapy Revenue by Country (2024-2033) & (US$ Million)
Table 60. US & Canada CAR-T Cell Therapy Sales by Country (2018-2023) & (K Units)
Table 61. US & Canada CAR-T Cell Therapy Sales by Country (2024-2033) & (K Units)
Table 62. Europe CAR-T Cell Therapy Sales by Type (2018-2023) & (K Units)
Table 63. Europe CAR-T Cell Therapy Sales by Type (2024-2033) & (K Units)
Table 64. Europe CAR-T Cell Therapy Revenue by Type (2018-2023) & (US$ Million)
Table 65. Europe CAR-T Cell Therapy Revenue by Type (2024-2033) & (US$ Million)
Table 66. Europe CAR-T Cell Therapy Sales by Application (2018-2023) & (K Units)
Table 67. Europe CAR-T Cell Therapy Sales by Application (2024-2033) & (K Units)
Table 68. Europe CAR-T Cell Therapy Revenue by Application (2018-2023) & (US$ Million)
Table 69. Europe CAR-T Cell Therapy Revenue by Application (2024-2033) & (US$ Million)
Table 70. Europe CAR-T Cell Therapy Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2033 (US$ Million)
Table 71. Europe CAR-T Cell Therapy Revenue by Country (2018-2023) & (US$ Million)
Table 72. Europe CAR-T Cell Therapy Revenue by Country (2024-2033) & (US$ Million)
Table 73. Europe CAR-T Cell Therapy Sales by Country (2018-2023) & (K Units)
Table 74. Europe CAR-T Cell Therapy Sales by Country (2024-2033) & (K Units)
Table 75. China CAR-T Cell Therapy Sales by Type (2018-2023) & (K Units)
Table 76. China CAR-T Cell Therapy Sales by Type (2024-2033) & (K Units)
Table 77. China CAR-T Cell Therapy Revenue by Type (2018-2023) & (US$ Million)
Table 78. China CAR-T Cell Therapy Revenue by Type (2024-2033) & (US$ Million)
Table 79. China CAR-T Cell Therapy Sales by Application (2018-2023) & (K Units)
Table 80. China CAR-T Cell Therapy Sales by Application (2024-2033) & (K Units)
Table 81. China CAR-T Cell Therapy Revenue by Application (2018-2023) & (US$ Million)
Table 82. China CAR-T Cell Therapy Revenue by Application (2024-2033) & (US$ Million)
Table 83. Asia CAR-T Cell Therapy Sales by Type (2018-2023) & (K Units)
Table 84. Asia CAR-T Cell Therapy Sales by Type (2024-2033) & (K Units)
Table 85. Asia CAR-T Cell Therapy Revenue by Type (2018-2023) & (US$ Million)
Table 86. Asia CAR-T Cell Therapy Revenue by Type (2024-2033) & (US$ Million)
Table 87. Asia CAR-T Cell Therapy Sales by Application (2018-2023) & (K Units)
Table 88. Asia CAR-T Cell Therapy Sales by Application (2024-2033) & (K Units)
Table 89. Asia CAR-T Cell Therapy Revenue by Application (2018-2023) & (US$ Million)
Table 90. Asia CAR-T Cell Therapy Revenue by Application (2024-2033) & (US$ Million)
Table 91. Asia CAR-T Cell Therapy Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2033 (US$ Million)
Table 92. Asia CAR-T Cell Therapy Revenue by Region (2018-2023) & (US$ Million)
Table 93. Asia CAR-T Cell Therapy Revenue by Region (2024-2033) & (US$ Million)
Table 94. Asia CAR-T Cell Therapy Sales by Region (2018-2023) & (K Units)
Table 95. Asia CAR-T Cell Therapy Sales by Region (2024-2033) & (K Units)
Table 96. Middle East, Africa and Latin America CAR-T Cell Therapy Sales by Type (2018-2023) & (K Units)
Table 97. Middle East, Africa and Latin America CAR-T Cell Therapy Sales by Type (2024-2033) & (K Units)
Table 98. Middle East, Africa and Latin America CAR-T Cell Therapy Revenue by Type (2018-2023) & (US$ Million)
Table 99. Middle East, Africa and Latin America CAR-T Cell Therapy Revenue by Type (2024-2033) & (US$ Million)
Table 100. Middle East, Africa and Latin America CAR-T Cell Therapy Sales by Application (2018-2023) & (K Units)
Table 101. Middle East, Africa and Latin America CAR-T Cell Therapy Sales by Application (2024-2033) & (K Units)
Table 102. Middle East, Africa and Latin America CAR-T Cell Therapy Revenue by Application (2018-2023) & (US$ Million)
Table 103. Middle East, Africa and Latin America CAR-T Cell Therapy Revenue by Application (2024-2033) & (US$ Million)
Table 104. Middle East, Africa and Latin America CAR-T Cell Therapy Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2033 (US$ Million)
Table 105. Middle East, Africa and Latin America CAR-T Cell Therapy Revenue by Country (2018-2023) & (US$ Million)
Table 106. Middle East, Africa and Latin America CAR-T Cell Therapy Revenue by Country (2024-2033) & (US$ Million)
Table 107. Middle East, Africa and Latin America CAR-T Cell Therapy Sales by Country (2018-2023) & (K Units)
Table 108. Middle East, Africa and Latin America CAR-T Cell Therapy Sales by Country (2024-2033) & (K Units)
Table 109. Bristol Myers Squibb Company Information
Table 110. Bristol Myers Squibb Description and Major Businesses
Table 111. Bristol Myers Squibb CAR-T Cell Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 112. Bristol Myers Squibb CAR-T Cell Therapy Product Model Numbers, Pictures, Descriptions and Specifications
Table 113. Bristol Myers Squibb Recent Developments
Table 114. Gilead Sciences Company Information
Table 115. Gilead Sciences Description and Major Businesses
Table 116. Gilead Sciences CAR-T Cell Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 117. Gilead Sciences CAR-T Cell Therapy Product Model Numbers, Pictures, Descriptions and Specifications
Table 118. Gilead Sciences Recent Developments
Table 119. Novartis Company Information
Table 120. Novartis Description and Major Businesses
Table 121. Novartis CAR-T Cell Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 122. Novartis CAR-T Cell Therapy Product Model Numbers, Pictures, Descriptions and Specifications
Table 123. Novartis Recent Developments
Table 124. Autolus Company Information
Table 125. Autolus Description and Major Businesses
Table 126. Autolus CAR-T Cell Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 127. Autolus CAR-T Cell Therapy Product Model Numbers, Pictures, Descriptions and Specifications
Table 128. Autolus Recent Developments
Table 129. Janssen Company Information
Table 130. Janssen Description and Major Businesses
Table 131. Janssen CAR-T Cell Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 132. Janssen CAR-T Cell Therapy Product Model Numbers, Pictures, Descriptions and Specifications
Table 133. Janssen Recent Developments
Table 134. JW Therapeutics Company Information
Table 135. JW Therapeutics Description and Major Businesses
Table 136. JW Therapeutics CAR-T Cell Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 137. JW Therapeutics CAR-T Cell Therapy Product Model Numbers, Pictures, Descriptions and Specifications
Table 138. JW Therapeutics Recent Developments
Table 139. Beijing Immunochina Medical Science & Technology Company Information
Table 140. Beijing Immunochina Medical Science & Technology Description and Major Businesses
Table 141. Beijing Immunochina Medical Science & Technology CAR-T Cell Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 142. Beijing Immunochina Medical Science & Technology CAR-T Cell Therapy Product Model Numbers, Pictures, Descriptions and Specifications
Table 143. Beijing Immunochina Medical Science & Technology Recent Developments
Table 144. Bioray Laboratories Company Information
Table 145. Bioray Laboratories Description and Major Businesses
Table 146. Bioray Laboratories CAR-T Cell Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 147. Bioray Laboratories CAR-T Cell Therapy Product Model Numbers, Pictures, Descriptions and Specifications
Table 148. Bioray Laboratories Recent Developments
Table 149. Key Raw Materials Lists
Table 150. Raw Materials Key Suppliers Lists
Table 151. CAR-T Cell Therapy Distributors List
Table 152. CAR-T Cell Therapy Customers List
Table 153. CAR-T Cell Therapy Market Trends
Table 154. CAR-T Cell Therapy Market Drivers
Table 155. CAR-T Cell Therapy Market Challenges
Table 156. CAR-T Cell Therapy Market Restraints
Table 157. Research Programs/Design for This Report
Table 158. Key Data Information from Secondary Sources
Table 159. Key Data Information from Primary Sources
List of Figures
Figure 1. CAR-T Cell Therapy Product Picture
Figure 2. Global CAR-T Cell Therapy Market Size Growth Rate by Type, 2018 VS 2022 VS 2033 (US$ Million)
Figure 3. Global CAR-T Cell Therapy Market Share by Type in 2022 & 2033
Figure 4. CD19 Product Picture
Figure 5. BCMA Product Picture
Figure 6. CD19/CD22 Product Picture
Figure 7. Other Product Picture
Figure 8. Global CAR-T Cell Therapy Market Size Growth Rate by Application, 2018 VS 2022 VS 2033 (US$ Million)
Figure 9. Global CAR-T Cell Therapy Market Share by Application in 2022 & 2033
Figure 10. Non-hodgkin Lymphoma
Figure 11. Multiple Myeloma
Figure 12. Acute Lymphoblastic Leukemia
Figure 13. Other
Figure 14. CAR-T Cell Therapy Report Years Considered
Figure 15. Global CAR-T Cell Therapy Revenue, (US$ Million), 2018 VS 2022 VS 2033
Figure 16. Global CAR-T Cell Therapy Revenue 2018-2033 (US$ Million)
Figure 17. Global CAR-T Cell Therapy Revenue Market Share by Region in Percentage: 2022 Versus 2033
Figure 18. Global CAR-T Cell Therapy Revenue Market Share by Region (2018-2033)
Figure 19. Global CAR-T Cell Therapy Sales 2018-2033 ((K Units)
Figure 20. Global CAR-T Cell Therapy Sales Market Share by Region (2018-2033)
Figure 21. US & Canada CAR-T Cell Therapy Sales YoY (2018-2033) & (K Units)
Figure 22. US & Canada CAR-T Cell Therapy Revenue YoY (2018-2033) & (US$ Million)
Figure 23. Europe CAR-T Cell Therapy Sales YoY (2018-2033) & (K Units)
Figure 24. Europe CAR-T Cell Therapy Revenue YoY (2018-2033) & (US$ Million)
Figure 25. China CAR-T Cell Therapy Sales YoY (2018-2033) & (K Units)
Figure 26. China CAR-T Cell Therapy Revenue YoY (2018-2033) & (US$ Million)
Figure 27. Asia (excluding China) CAR-T Cell Therapy Sales YoY (2018-2033) & (K Units)
Figure 28. Asia (excluding China) CAR-T Cell Therapy Revenue YoY (2018-2033) & (US$ Million)
Figure 29. Middle East, Africa and Latin America CAR-T Cell Therapy Sales YoY (2018-2033) & (K Units)
Figure 30. Middle East, Africa and Latin America CAR-T Cell Therapy Revenue YoY (2018-2033) & (US$ Million)
Figure 31. The CAR-T Cell Therapy Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2022
Figure 32. The Top 5 and 10 Largest Manufacturers of CAR-T Cell Therapy in the World: Market Share by CAR-T Cell Therapy Revenue in 2022
Figure 33. Global CAR-T Cell Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 34. Global CAR-T Cell Therapy Sales Market Share by Type (2018-2033)
Figure 35. Global CAR-T Cell Therapy Revenue Market Share by Type (2018-2033)
Figure 36. Global CAR-T Cell Therapy Sales Market Share by Application (2018-2033)
Figure 37. Global CAR-T Cell Therapy Revenue Market Share by Application (2018-2033)
Figure 38. US & Canada CAR-T Cell Therapy Sales Market Share by Type (2018-2033)
Figure 39. US & Canada CAR-T Cell Therapy Revenue Market Share by Type (2018-2033)
Figure 40. US & Canada CAR-T Cell Therapy Sales Market Share by Application (2018-2033)
Figure 41. US & Canada CAR-T Cell Therapy Revenue Market Share by Application (2018-2033)
Figure 42. US & Canada CAR-T Cell Therapy Revenue Share by Country (2018-2033)
Figure 43. US & Canada CAR-T Cell Therapy Sales Share by Country (2018-2033)
Figure 44. U.S. CAR-T Cell Therapy Revenue (2018-2033) & (US$ Million)
Figure 45. Canada CAR-T Cell Therapy Revenue (2018-2033) & (US$ Million)
Figure 46. Europe CAR-T Cell Therapy Sales Market Share by Type (2018-2033)
Figure 47. Europe CAR-T Cell Therapy Revenue Market Share by Type (2018-2033)
Figure 48. Europe CAR-T Cell Therapy Sales Market Share by Application (2018-2033)
Figure 49. Europe CAR-T Cell Therapy Revenue Market Share by Application (2018-2033)
Figure 50. Europe CAR-T Cell Therapy Revenue Share by Country (2018-2033)
Figure 51. Europe CAR-T Cell Therapy Sales Share by Country (2018-2033)
Figure 52. Germany CAR-T Cell Therapy Revenue (2018-2033) & (US$ Million)
Figure 53. France CAR-T Cell Therapy Revenue (2018-2033) & (US$ Million)
Figure 54. U.K. CAR-T Cell Therapy Revenue (2018-2033) & (US$ Million)
Figure 55. Italy CAR-T Cell Therapy Revenue (2018-2033) & (US$ Million)
Figure 56. Russia CAR-T Cell Therapy Revenue (2018-2033) & (US$ Million)
Figure 57. China CAR-T Cell Therapy Sales Market Share by Type (2018-2033)
Figure 58. China CAR-T Cell Therapy Revenue Market Share by Type (2018-2033)
Figure 59. China CAR-T Cell Therapy Sales Market Share by Application (2018-2033)
Figure 60. China CAR-T Cell Therapy Revenue Market Share by Application (2018-2033)
Figure 61. Asia CAR-T Cell Therapy Sales Market Share by Type (2018-2033)
Figure 62. Asia CAR-T Cell Therapy Revenue Market Share by Type (2018-2033)
Figure 63. Asia CAR-T Cell Therapy Sales Market Share by Application (2018-2033)
Figure 64. Asia CAR-T Cell Therapy Revenue Market Share by Application (2018-2033)
Figure 65. Asia CAR-T Cell Therapy Revenue Share by Region (2018-2033)
Figure 66. Asia CAR-T Cell Therapy Sales Share by Region (2018-2033)
Figure 67. Japan CAR-T Cell Therapy Revenue (2018-2033) & (US$ Million)
Figure 68. South Korea CAR-T Cell Therapy Revenue (2018-2033) & (US$ Million)
Figure 69. China Taiwan CAR-T Cell Therapy Revenue (2018-2033) & (US$ Million)
Figure 70. Southeast Asia CAR-T Cell Therapy Revenue (2018-2033) & (US$ Million)
Figure 71. India CAR-T Cell Therapy Revenue (2018-2033) & (US$ Million)
Figure 72. Middle East, Africa and Latin America CAR-T Cell Therapy Sales Market Share by Type (2018-2033)
Figure 73. Middle East, Africa and Latin America CAR-T Cell Therapy Revenue Market Share by Type (2018-2033)
Figure 74. Middle East, Africa and Latin America CAR-T Cell Therapy Sales Market Share by Application (2018-2033)
Figure 75. Middle East, Africa and Latin America CAR-T Cell Therapy Revenue Market Share by Application (2018-2033)
Figure 76. Middle East, Africa and Latin America CAR-T Cell Therapy Revenue Share by Country (2018-2033)
Figure 77. Middle East, Africa and Latin America CAR-T Cell Therapy Sales Share by Country (2018-2033)
Figure 78. Brazil CAR-T Cell Therapy Revenue (2018-2033) & (US$ Million)
Figure 79. Mexico CAR-T Cell Therapy Revenue (2018-2033) & (US$ Million)
Figure 80. Turkey CAR-T Cell Therapy Revenue (2018-2033) & (US$ Million)
Figure 81. Israel CAR-T Cell Therapy Revenue (2018-2033) & (US$ Million)
Figure 82. GCC Countries CAR-T Cell Therapy Revenue (2018-2033) & (US$ Million)
Figure 83. CAR-T Cell Therapy Value Chain
Figure 84. CAR-T Cell Therapy Production Process
Figure 85. Channels of Distribution
Figure 86. Distributors Profiles
Figure 87. Bottom-up and Top-down Approaches for This Report
Figure 88. Data Triangulation
Figure 89. Key Executives Interviewed